Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Cardioxyl Pharmaceuticals
Exchange East, Suite 212, 1450 Raleigh Road
Chapel Hill, NC 27517
Phone: 919-869-8585

Cardioxyl Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery and development of new classes of safe and effective therapeutic agents for the treatment of cardiovascular disease. Cardioxyl has developed industry-leading expertise in the chemistry, biology and clinical applications of nitroxyl (HNO) technology. The company's core HNO platform has generated several pre-clinical and clinical candidates.

Key Contact
Name
Christopher Kroeger
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/13/12 $28,000,000 Series B OrbiMed Advisors
Osage University Partners
The Aurora Funds
undisclosed